Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Project leader/senior scientist at UniBern.
2 years in pharma industry.
8 years of research activity on the ECS
Full Professor at UniBern.
Collaboration with pharma industry.
10+ years of research activity on the ECS.
Andrea Chicca CEO will present a talk entitled “Selective Endocannabinoid Re-uptake Inhibitors (SERIs): A New Class of ECS Modulators for Safe & Effective Treatment of Neuropsychiatric Disorders” at the 7th CB1, CB2 & Cannabinoid Drug Development Summit in Boston from November 18th-20th.
Synendos Secures Innosuisse Funding to Advance Clinical Development of SYT-510 Synendos AG is excited to announce that it has been...
Andrea Chicca (CEO) and Simon Russell (CCO) will attend the Bio Europe conference in Stockholm from 4th to 6th of November 2024.
Andrea Chicca (CEO) and Isabella Premoli (Principal Clinical Scientist) will attend the 37th ECNP Congress in Milan from 21-24 September...
Comments